Norges Bank’s Agilon Health AGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-57,368
Closed -$3.3M 44
2025
Q2
$3.3M Buy
+57,368
New +$4.6M ﹤0.01% 1373
2024
Q4
Sell
-101,526
Closed -$9.97M 1846
2024
Q3
$9.97M Buy
101,526
+66,753
+192% +$8.62M ﹤0.01% 1364
2024
Q2
$5.69M Sell
34,773
-34,346
-50% -$4.89M ﹤0.01% 1529
2024
Q1
$10.5M Sell
69,119
-19,811
-22% -$3.3M ﹤0.01% 1429
2023
Q4
$27.9M Sell
88,930
-25,788
-22% -$9.33M ﹤0.01% 1161
2023
Q3
$50.9M Sell
114,718
-27,299
-19% -$12.3M 0.01% 829
2023
Q2
$61.6M Buy
142,017
+90,922
+178% +$51.1M 0.01% 757
2023
Q1
$30.3M Sell
51,095
-3,797
-7% -$2.13M 0.01% 1070
2022
Q4
$22.1M Buy
54,892
+5,243
+11% +$2.46M 0.01% 1209
2022
Q3
$29.1M Buy
49,649
+1,602
+3% +$959K 0.01% 1020
2022
Q2
$26.2M Buy
48,047
+9,117
+23% +$4.61M 0.01% 1111
2022
Q1
$24.7M Buy
38,930
+6,208
+19% +$3.2M 0.01% 1284
2021
Q4
$22.1M Buy
+32,722
New +$19.9M ﹤0.01% 1425
2021
Q3
Sell
-7,152
Closed -$7.25M 2271
2021
Q2
$7.25M Buy
+7,152
New +$6.27M ﹤0.01% 1841

Other funds holding AGL

Norges Bank's AGL Position: Q3 2025 in Review

Norges Bank sold out of Agilon Health (AGL) in Q3 2025, closing a stake of 57,368 shares — an estimated $3.3M sold.

Norges Bank first reported a position in AGL in Q2 2021 and held it in 14 quarters. The position peaked at $61.6M in Q2 2023. 190 funds tracked by Wall St. Rank hold AGL as of Q3 2025.

  • Norges Bank reported no remaining Agilon Health position as of Q3 2025 after selling out during the quarter.
  • Norges Bank sold 57,368 Agilon Health shares in Q3 2025, an estimated $3.3M.
  • Norges Bank first reported a position in Agilon Health in Q2 2021 and held it in 14 quarters.
  • Norges Bank's Agilon Health position peaked at $61.6M in Q2 2023.
  • 190 funds tracked by Wall St. Rank held Agilon Health as of Q3 2025.

Based on Norges Bank's 13F filing for Q3 2025.